Cynata already in the US which is a huge advantage. Just have a look at OSIRIS,which doubled last night on clinical studies. M/cap cheap compared to US companies even with a billion shares on issue.
ECQ Price at posting:
2.1¢ Sentiment: ST Buy Disclosure: Held
